CXCR5 and B-cell chronic lymphocytic leukemia: As the presence of CXCR5+PD‐1+ CD8 T cells at the tumor site may be important in order to respond to PD‐1 ICB, we analyzed CLL LN biopsies for the presence of CXCR5+ CD8 T cells by histo‐cytometry analysis.